Since EDI3 expression is regulated by proteins downstream of PI3K/Akt, which are closely linked to tumour development and progression, we next investigated whether the high EDI3 expression in the ER − HER2 + subtype is associated with improved viability, making it a potential therapeutic target. This evidence concerns the gene PIK3CA and neoplasm.